Clinical efficacy comparison of mifepristone and gestrinone in severe endometriosis after conservative operation
article
OA: closed
CC0
AI-generated summary
Mifepristone and gestrinone were compared for severe endometriosis after conservative surgery, with mifepristone showing a lower incidence of adverse reactions and similar pregnancy rates.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective To compare the clinical effect of mifepristone and gestrinone in severe endometriosis after conservative operation.Methods 70 cases patients undergong conservative operation and diagnosed as endometriosis by pathologcal examination were randomly divided into mifepristone group and gestrinone group,each of 35 cases.Mifepristone group took mifepristone 2.5mg,one time a day;Gestrinone group took gestrinone 12.5 mg,twice a week.The treatment started after one week and continued for 6 months.After treatmeat,compared clinical effect,pregnancy situation and adverse reaction.Results Mifepristone group with infertility before surgery in 7 cases,5 cases of pregnancy after treatment;Gestrinone group with infertility before surgery in 4 cases,3 cases of pregnancy after treatment.All discontinued within six months of pregnancy.The incidence of adverse reaction of mifepristone group[14.3%(5/35)] was lower than that of gestrinone group[37.1%(13/35)],the difference was statistically significant(P0.05).Conclusion Application of mifepristone and gestrinone in consolidation therapy after operation of endometriosis is safe and effective,but mifepristone′s adverse reaction is lower than gestrinone.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK